In Today’s News

STOP! Don’t buy any more Bitcoin [sponsor]

Economic jitters will not derail Americans’ generosity on Giving Tuesday, expert says

NEW YORK, Dec 1 (Reuters) – December 2 is the date this year when nonprofit organizations will celebrate Giving Tuesday, a global movement encouraging philanthropy on the heels of Black Friday and Cyber Monday.Michael Thatcher, president and chief executive officer of Charity Navigator, which rates nonprofit …

Must-See 20 Second Trading Demo [sponsor]
Larry Benedict’s hedge fund went 20 years without a single losing year and was ranked in the top 1% in the entire world by Barron’s. Click here to learn his secret.

AI companies’ safety practices fail to meet global standards, study shows

The institute said the safety evaluation, conducted by an independent panel of experts, found that while the companies were busy racing to develop superintelligence, none had a robust strategy for controlling such advanced systems. The study comes amid heightened public concern about the societal impact of sm …

Is This the Next Major Pharma Acquisition? [sponsor]
A revolutionary platform demonstrating safer cancer treatment outcomes mirrors the same strategy that resulted in a $43 billion buyout. This time, however, the company behind the innovation remains under the radar. Explore the early-stage company generating significant interest.

Chevron to spend up to $19 billion next year in focus on US, Guyana oil production

HOUSTON, Dec 3 (Reuters) – Chevron said on Wednesday that capital expenditureÂ for 2026 will be between $18 billion and $19 billion as the oil major focuses on production in the U.S. and investments connected to a recently-acquired oil stake in Guyana.The range is at the low-end of previous guidance that pu …

Embark on Your Journey to Dividend Investing Success [sponsor]
Are you aiming for effortless income generation and a resilient portfolio? Our 5 Essential Dividend Guides are designed to steer your investment decisions, whether you’re just starting or looking to refine your strategy. Claim Your FREE Copy Now (Just Cover Shipping)!

Data supports current US policy of hepatitis B vaccine for newborns, as officials push for change

CHICAGO, Dec 2 (Reuters) – An independent review released on Tuesday by vaccine experts of more than 400 studies and reports found that long-standing U.S. policy of giving the hepatitis B vaccine to newborns has cut infections in children by more than 95%.The policy, adopted in 1991, will be discussed and vot …

Last Chance to Join: RAD Intel at $0.85/Share [sponsor]
With an impressive valuation increase of 4,900% and multi-million dollar contracts secured, RAD Intel has elevated its share price. However, there is still an opportunity to participate in the current offering. Secure your allocation at just $0.85 before it’s too late! *DISCLOSURE: This is a paid advertisement for RAD Intel’s Reg A offering and carries risks, including the potential loss of principal. For further details, please review the offering circular and associated risks at invest.radintel.ai. *The valuation has been established by RAD Intel.

The Third Revolution in Warfare: A 5,633% Investment Opportunity [sponsor]

Could trigger massive AI boom for this company [sponsor]

Get My $499 Strategy for Just $19 [sponsor]

DISCLAIMER
This is a paid advertisement for informational and educational purposes only and does not constitute financial advice. Investing involves risk and may not be suitable for all individuals. Past performance does not guarantee future results.
Trading Stocks Now is operated by Investing Media Solutions, LLC. We are not licensed financial advisors. Always consult with a certified financial professional before making investment decisions.

IMPORTANT NOTICE AND DISCLAIMER
Investing Media Solutions, LLC (“IMS”), the owner of this website (the “Website”), cannot guarantee the accuracy or completeness of the information contained in any article, email, newsletter, or other publication posted on or viewed in connection with this website (the “Publications”). The author or authors of those Publications are solely responsible for their contents. IMS has not done any research or due diligence into the markets, industries, or companies which may appear or be mentioned in the Publications. IMS will NOT be liable for any loss or damage caused by a reader’s reliance on information posted on the Website or contained in the Publications.

FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE.
This Website and the Publications are for educational and informational purposes only. This Website and the Publications do not purport to be a complete analysis of any company’s financial position. This Website, the Publications or any statements made in the Publications are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual.This Website or the statements made in the Publications should NOT be relied upon for purposes of transacting in any securities posted on the Website or mentioned in the Publications, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security posted on this Website or mentioned in any Publications.b>

SUBSTANTIAL RISK IN INVESTMENT.
Any individual who chooses to invest in any securities including those mentioned in the Publications should do so with caution.Investing or transacting in securities involves substantial risk; you may lose some, all, or possibly more than your original investment.Readers bear responsibility for their own investment research and decisions and should review all investment decisions with a licensed or registered investment professional.

NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER
Neither IMS nor any of its respective owners or employees are registered or licensed as a securities broker-dealer, broker, an investment advisor, or an investment advisor representative with the U.S. Securities and Exchange Commission (SEC), any state securities regulatory authority, or any self-regulatory organization.

For full policies, see our: Disclaimer | Privacy | Terms

Trading Stocks Now
203 N La Salle Street, Suite 2100 | Chicago, IL 60601

unsubscribe

AI companies’ safety practices fail to meet global standards, study shows

In Today’s News

STOP! Don’t buy any more Bitcoin [sponsor]

Economic jitters will not derail Americans’ generosity on Giving Tuesday, expert says

AI companies’ safety practices fail to meet global standards, study shows

Chevron to spend up to $19 billion next year in focus on US, Guyana oil production

Data supports current US policy of hepatitis B vaccine for newborns, as officials push for change

You Might Also Like

The Third Revolution in Warfare: A 5,633% Investment Opportunity [sponsor]

Could trigger massive AI boom for this company [sponsor]

Get My $499 Strategy for Just $19 [sponsor]

More From Author

Data supports current US policy of hepatitis B vaccine for newborns, as officials push for change

Chevron to spend up to $19 billion next year in focus on US, Guyana oil production

AI companies’ safety practices fail to meet global standards, study shows

Data supports current US policy of hepatitis B vaccine for newborns, as officials push for change

Live Market Pulse

Recent Posts

Categories

In Today’s News

You Might Also Like

Live Market Pulse

Sign up for our free Trading Stocks Now Newsletter!

Recent Posts

Categories